Kathleen S. Capps, See Remarks at ENANTA PHARMACEUTICALS INC (ENTA), sold 323 shares at $14.23 ($5K) on 2025-12-05, disclosed to the SEC on 2025-12-05.
Open-market sale of $5k ENTA by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.